These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2042019)

  • 1. Screening for haemochromatosis: influence of analytical imprecision, diagnostic limit and prevalence on test validity.
    Wiggers P; Dalhøj J; Hyltoft Petersen P; Blaabjerg O; Hørder M
    Scand J Clin Lab Invest; 1991 Apr; 51(2):143-8. PubMed ID: 2042019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing manifestations of hereditary haemochromatosis through population based screening.
    Haddow JE; Ledue TB
    J Med Screen; 1994 Jan; 1(1):16-21. PubMed ID: 8790482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population screening for haemochromatosis: a unifying analysis of published intervention trials.
    Bradley LA; Haddow JE; Palomaki GE
    J Med Screen; 1996; 3(4):178-84. PubMed ID: 9041481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A screening test for detecting iron overload in population studies.
    Baynes RD; Meyer TE; Bothwell TH; McNamara L
    S Afr Med J; 1988 Aug; 74(4):167-9. PubMed ID: 3406874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transferrin index: an alternative method for calculating the iron saturation of transferrin.
    Beilby J; Olynyk J; Ching S; Prins A; Swanson N; Reed W; Harley H; Garcia-Webb P
    Clin Chem; 1992 Oct; 38(10):2078-81. PubMed ID: 1394993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum iron and total iron-binding capacity compared with serum ferritin in assessment of iron deficiency.
    Peter F; Wang S
    Clin Chem; 1981 Feb; 27(2):276-9. PubMed ID: 7460279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 30-year database.
    Adams PC; Gregor JC; Kertesz AE; Valberg LS
    Gastroenterology; 1995 Jul; 109(1):177-88. PubMed ID: 7797016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Accuracy of Serum Iron and Total Iron Binding Capacity (TIBC) in Iron Deficiency State.
    Asif N; Ijaz A; Rafi T; Haroon ZH; Bashir S; Ayyub M
    J Coll Physicians Surg Pak; 2016 Dec; 26(12):958-961. PubMed ID: 28043306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic efficacy of screening tests for hereditary hemochromatosis.
    Borwein S; Ghent CN; Valberg LS
    Can Med Assoc J; 1984 Oct; 131(8):895-901. PubMed ID: 6593112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Elevated serum ferritin and hemochromatosis in general practice].
    Mouland G; Bratland B; Hornnes MB; Asser HP; Lier J; Reiso H; Rygh E
    Tidsskr Nor Laegeforen; 2005 Jan; 125(1):20-2. PubMed ID: 15643457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hemochromatosis among first-time and repeat blood donors in Norway.
    Bell H; Thordal C; Raknerud N; Hansen T; Bosnes V; Halvorsen R; Heier HE; Try K; Leivestad T; Thomassen Y
    J Hepatol; 1997 Feb; 26(2):272-9. PubMed ID: 9059946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of haemochromatosis amongst asymptomatic Australians.
    Leggett BA; Halliday JW; Brown NN; Bryant S; Powell LW
    Br J Haematol; 1990 Apr; 74(4):525-30. PubMed ID: 2346731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum-ferritin in diagnosis of haemochromatosis. A study of 43 families.
    Halliday JW; Russo AM; Cowlishaw JL; Powell LW
    Lancet; 1977 Sep; 2(8039):621-4. PubMed ID: 71445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests.
    Bassett ML; Halliday JW; Ferris RA; Powell LW
    Gastroenterology; 1984 Sep; 87(3):628-33. PubMed ID: 6745616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of serum tests for iron deficiency in hospitalized patients.
    Burns ER; Goldberg SN; Lawrence C; Wenz B
    Am J Clin Pathol; 1990 Feb; 93(2):240-5. PubMed ID: 2242107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for haemochromatosis: prevalence among Danish blood donors.
    Wiggers P; Dalhøj J; Kiaer H; Ring-Larsen H; Petersen PH; Blaabjerg O; Hørder M
    J Intern Med; 1991 Sep; 230(3):265-70. PubMed ID: 1895049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of haemochromatosis gene mutations in the general population: implications for screening.
    Burt MJ; George PM; Upton JD; Collett JA; Frampton CM; Chapman TM; Walmsley TA; Chapman BA
    Gut; 1998 Dec; 43(6):830-6. PubMed ID: 9824612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for iron overload in the Turkish population.
    Barut G; Balci H; Bozdayi M; Hatemi I; Ozcelik D; Senturk H
    Dig Dis; 2003; 21(3):279-85. PubMed ID: 14571105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic haemochromatosis.
    Rosalki SB
    Int J Clin Pract; 2002 Oct; 56(8):609-10. PubMed ID: 12425371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of primary hemochromatosis].
    Swinkels DW; Marx JJ
    Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1404-8. PubMed ID: 10422553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.